Items where Author is "Tomlinson, JW"

GÓMEZ, C., ALIMAJSTOROVIC, Z., OTHONOS, N., WINTER, D.V., WHITE, S., LAVERY, G.G., TOMLINSON, J.W., SINCLAIR, A.J. and ODERMATT, A., 2024. Identification of a human blood biomarker of pharmacological 11β‐hydroxysteroid dehydrogenase 1 inhibition. British Journal of Pharmacology, 181 (5), pp. 698-711. ISSN 0007-1188

DINEEN, R.A., MARTIN-GRACE, J., AHMED, K.M.S., TAYLOR, A.E., SHAHEEN, F., SCHIFFER, L., GILLIGAN, L.C., LAVERY, G.G., FRIZELLE, I., GUNNESS, A., GARRAHY, A., HANNON, A.M., METHLIE, P., EYSTEIN, S.H., STEWART, P.M., TOMLINSON, J.W., HAWLEY, J.M., KEEVIL, B.G., O’REILLY, M.W., SMITH, D., MCDERMOTT, J., HEALY, M.-L., AGHA, A., PAZDERSKA, A., GIBNEY, J., BEHAN, L.-A., THOMPSON, C.J., ARLT, W. and SHERLOCK, M., 2023. Tissue glucocorticoid metabolism in adrenal insufficiency: a prospective study of dual-release hydrocortisone therapy. The Journal of Clinical Endocrinology and Metabolism, 108 (12), pp. 3178-3189. ISSN 0021-972X

WESTGATE, C.S.J., MARKEY, K., MITCHELL, J.L., YIANGOU, A., SINGHAL, R., STEWART, P., TOMLINSON, J.W., LAVERY, G.G., MOLLAN, S.P. and SINCLAIR, A.J., 2022. Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension. European Journal of Endocrinology, 187 (2), pp. 323-333. ISSN 0804-4643

WESTGATE, C.S.J., BOTFIELD, H.F., ALIMAJSTOROVIC, Z., YIANGOU, A., WALSH, M., SMITH, G., SINGHAL, R., MITCHELL, J.L., GRECH, O., MARKEY, K.A., HEBENSTREIT, D., TENNANT, D.A., TOMLINSON, J.W., MOLLAN, S.P., LUDWIG, C., AKERMAN, I., LAVERY, G.G. and SINCLAIR, A.J., 2021. Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension. JCI Insight, 6 (10): e145346. ISSN 2379-3708

HARDY, R.S., BOTFIELD, H., MARKEY, K., MITCHELL, J.L., ALIMAJSTOROVIC, Z., WESTGATE, C.S.J., SAGMEISTER, M., FAIRCLOUGH, R.J., OTTRIDGE, R.S., YIANGOU, A., STORBECK, K.-H.H., TAYLOR, A.E., GILLIGAN, L.C., ARLT, W., STEWART, P.M., TOMLINSON, J.W., MOLLAN, S.P., LAVERY, G.G. and SINCLAIR, A.J., 2021. 11βHSD1 inhibition with AZD4017 improves lipid profiles and lean muscle mass in idiopathic intracranial hypertension. The Journal of Clinical Endocrinology and Metabolism, 106 (1), pp. 174-187. ISSN 0021-972X

DOIG, C.L., FLETCHER, R.S., MORGAN, S.A., MCCABE, E.L., LARNER, D.P., TOMLINSON, J.W., STEWART, P.M., PHILP, A. and LAVERY, G.G., 2017. 11β-HSD1 modulates the set point of brown adipose tissue response to glucocorticoids in male mice. Endocrinology, 158 (6), pp. 1964-1976. ISSN 0013-7227

LARNER, D.P., MORGAN, S.A., GATHERCOLE, L.L., DOIG, C.L., GUEST, P., WESTON, C., HAZELDINE, J., TOMLINSON, J.W., STEWART, P.M. and LAVERY, G.G., 2016. Male 11β-HSD1 knockout mice fed trans-fats and fructose are not protected from metabolic syndrome or nonalcoholic fatty liver disease. Endocrinology, 157 (9), pp. 3493-3504. ISSN 0013-7227

AHMED, A., RABBITT, E., BRADY, T., BROWN, C., GUEST, P., BUJALSKA, I.J., DOIG, C., NEWSOME, P.N., HUBSCHER, S., ELIAS, E., ADAMS, D.H., TOMLINSON, J.W. and STEWART, P.M., 2012. A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease. PLoS ONE, 7 (2): e29531. ISSN 1932-6203